What is Ardent Health Partners's equity method investments?

Ardent Health Partners (ARDT) reported equity method investments of $18.8M in Q1 2026.

What does equity method investments mean?

Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.

Ardent Health Partners ARDT Equity Method Investments

Equity Method Investments at other companies

Surgery Partners, Inc.SGRY

$225.4M+3.1%

National HealthcareNHC

$41.98M+38.6%

Astrana HealthASTH

$27.26M-28.3%

Option Care Health, Inc.OPCH

$29.6M+13.0%

PACS GroupPACS

$29.82M-16.2%

Healthpeak PropertiesDOC

$530.35M-44.3%

Other financials

Income statement

See full

Revenue$1.6B+7.0%

Gross profit$1.6B+6.7%

Net income$39.9M-3.7%

EPS (diluted)$0.28-3.4%

Balance sheet

See full

Cash & equivalents$609.7M+23.2%

Total debt$1.2B+1.7%

Total equity$1.3B+13.8%

Total assets$5.3B+7.0%

Cash flow

See full

Operating cash flow-$60.2M-143%

CapEx$28.1M+22.6%

Free cash flow-$88.3M-85.2%

Valuation

See full

Market cap$1.35B-37.7%

Enterprise value$1.91B-31.9%

P/E10×+0.4×

P/S0.2×-0.1×

Profitability

See full

Gross margin97.5%-0.1pp

Net margin2.1%-1.6pp

FCF margin3.4%+1.4pp

Returns & leverage

See full

Return on equity10.7%-9.0pp

Debt / equity0.9×-0.1×

Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Ardent Health Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardent Health Partners's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardent Health Partners's equity method investments?: Ardent Health Partners (ARDT) reported equity method investments of $18.8M in Q1 2026.
What does equity method investments mean?: Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.